Early detection saves lives. Logically, this statement makes sense. If we could detect breast cancer earlier with a positive mammogram than it would have been detected as a lump in the breast, the cancer would have less time to have spread to surrounding or distant sites. As survival is directly linked with the degree that the cancer has spread from the initial tumour site at diagnosis 1 , we expect mammography to reduce breast cancer mortality. Public opinion largely favours this logic, and the mantra of early detection saves lives resonates throughout breast cancer awareness groups. 2, 3 Many compelling breast cancer survivor stories state "Mammography has saved my life". These stories are common; on average, one cancer survivor story was published every month in 18 daily newspapers and magazines sampled over a four month period. 4 For decades, this public opinion was congruent with scientific evidence and opinion on mammography. However, on November 16 th , 2009, the U.S. Preventive Services Task Force released controversial recommendations on mammography screening, no longer recommending women aged 40-49 to receive mammograms, as was previously advised. 5 Other recommendations, including for women to receive a mammogram every two years between the ages of 50 and 74, and ceasing mammography screening at age 75 remained unchanged. These recommendations were later mirrored by the Canadian Task Force on Preventive Health Care. 6 These decisions were made in light of recent evidence that mammography may not be as effective in reducing breast cancer mortality as previously thought. In addition, some argue that mammography in any average risk age group may be causing more harm than good as a consequence of overdiagnosis and overtreatment of breast cancer. In this Mythbuster, I will examine the evidence both for and against the effectiveness of mammography in breast cancer screening, with the goal of providing physicians with a succinct review on this now-controversial topic, allowing them to discuss both the benefits and potential harms of mammography screening with their patients.
The effectiveness of mammography in detecting breast cancer has been studied in over 600,000 women in many large randomized controlled trials. The most comprehensive systematic review and meta-analysis of these studies to date found a 19% decrease in breast cancer mortality due to mammography. 7 In addition, a measurable a decline in breast cancer mortality rates has occurred in the past few decades. [8] [9] [10] [11] In Canada, breast cancer mortality has fallen by almost 40% between its peak in 1986 to the most recent estimate in 2012. 1 Earlier detection of breast cancer due to mammography has received much of the praise for this decline. However, many improvements in breast cancer treatment and increased breast cancer awareness have also occurred over the same time period. How much of the observed decrease in breast cancer mortality can be attributed to mammography screening?
The best evidence to answer this question comes from Norway, where mammographic screening was implemented in a systematic geographic manner over a time period of 9 years. 12 This study found that long-term breast cancer mortality was reduced by 28% in the areas with mammography screening. However, breast cancer mortality was also reduced by 18% in the population which did not have access to mammography screening over the same time period. Therefore, mammography was only responsible for a third of the reduction in mortality observed after implementing a screening program, and only reduced breast cancer mortality by 10% in this population. The other 18% in decreased mortality can be attributed to improved treatments 15 After implementing a mammography screening program, we would expect to see fewer of late-stage breast cancer diagnoses along with an increase in earlystage diagnoses. While mammography has detected significantly more earlier-stage breast cancers 13 , analysis of time trends in late-stage breast cancer diagnoses has found that the incidence of late-stage breast cancer diagnoses has not decreased, and instead has remained level after the implementation of mammographic screening. 14 There are many potential harms of mammography screening. False-positive tests results, when a mammogram suggests that breast cancer may be present but upon further investigation it is determined that no cancer is present, lead to significant psychological distress. 16 Overdiagnosis and overtreatment occur when a woman is diagnosed with breast cancer, which is actually present (i.e. it isn't misdiagnosed), but the cancer would have never caused symptoms or a risk of death. This occurs because mammograms preferentially detect slow growing breast cancers that would have never put the patient at risk from dying of breast cancer, known as length bias. 17 It has been estimated that over the last 30 years in the United States, 1.3 million women have been overdiagnosed and overtreated due to mammography detection of breast cancer in the last 30 years. 18 How can we put these risks in perspective? Of 2000 women who are invited for mammography screening for a 10 year period, one woman will have her life prolonged because of mammography. 7 However, 10 women will be overdiagnosed with breast cancer and treated unnecessarily, which would not have been diagnosed if she wasn't screened screening. 200 women will receive a false positive result over this time period, leading to significant psychological distress. 16 Clearly, these risks are significant when compared to the benefits of mammography screening.
Therefore, we can see that the benefits of mammography screening for detecting breast cancer aren't as clear cut as previously thought, and there is substantial evidence that there are many harms that are associated with mammography screening. While professional opinions greatly differ on the balance of the benefits and potential harms, ultimately the decision of whether to undergo mammography screening must lie entirely with the patient. The patient should be informed of both the benefits and potential harms associated with mammography screening, and make a decision based off of their own personal values and beliefs of mammography.
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